Published in Vaccine Weekly, December 10th, 2003
The samples will be used to better understand the human immune system's ability to fight monkeypox, information that will be critical for future vaccine development.
"The recent monkeypox outbreak in the Midwest provides a unique and important opportunity for medical research," explained Mark Slifka, PhD, assistant scientist at the OHSU Vaccine and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-12-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.